Dange Veerapanane

Title: Dange Veerapanane: Innovator in Oligonucleotide Technology

Introduction

Dange Veerapanane is a notable inventor based in Lawrence, KS (US). He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotides for therapeutic applications. His innovative work focuses on inhibiting the expression of interleukin genes, which play a crucial role in various inflammatory processes.

Latest Patents

Dange Veerapanane holds 1 patent for his invention titled "Il-15 triplex oligonucleotides - Oligomers for inhibiting expression of interleukin genes." This patent describes a novel approach where each oligomer, when introduced into a cell, is capable of forming a transcription-inhibiting complex with an interleukin gene. The oligomer is designed to bind in an antiparallel orientation to the polypurine strand of a polypurine-polypyrimidine region of the interleukin gene, showcasing a unique mechanism of action.

Career Highlights

Dange Veerapanane is currently associated with Hisamitsu Pharmaceutical Company, Inc., where he continues to advance his research in the field of oligonucleotide technology. His work has the potential to lead to new therapeutic strategies for managing inflammatory diseases.

Collaborations

Dange has collaborated with esteemed colleagues such as Iwao Nozawa and Shoji Hamanaka, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Dange Veerapanane's contributions to biotechnology, particularly through his patented oligonucleotide technology, highlight his role as a significant inventor in the field. His work promises to impact therapeutic approaches to inflammatory conditions, showcasing the importance of innovation in medical science.